Convatec upgrades 2021 sales forecast

In a Q3 trading update, UK-based Convatec has slightly increased its organic revenue growth expectation for the full year. Convatec now thinks revenue growth in the high end of the previously reported interval of 3.5-5 percent is likely.
Photo: Convatec
Photo: Convatec
BY MARKETWIRE, TRANSLATED BY DANIEL PEDERSEN

On Friday morning, UK-based medtech company Convatec, a competitor of Denmark-based Coloplast, released its third quarter report of the year.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading